Matinas BioPharma Holdings, Inc. (MTNB) AMEX
0.63
-0.0076(-1.19%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.63
-0.0076(-1.19%)
Currency In USD
| Previous Close | 0.64 |
| Open | 0.61 |
| Day High | 0.64 |
| Day Low | 0.61 |
| 52-Week High | 3.09 |
| 52-Week Low | 0.48 |
| Volume | 2,309 |
| Average Volume | 30,261 |
| Market Cap | 3.5M |
| PE | -0.18 |
| EPS | -3.42 |
| Moving Average 50 Days | 0.63 |
| Moving Average 200 Days | 1.09 |
| Change | -0.01 |
Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors
GlobeNewswire Inc.
Mar 11, 2025 11:00 AM GMT
BEDMINSTER, N.J., March 11, 2025 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) today announced the appointment of biotech industry veterans Keith Murphy and Edward Neugeboren to its Board of Directors as independent mem
Matinas BioPharma Announces Agreement for the Acquisition of Preferred Stock and Appointment of Dr. Robin L. Smith to the Board of Directors
GlobeNewswire Inc.
Feb 13, 2025 10:00 PM GMT
BEDMINSTER, N.J., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) (the “Company”) today announced that the Company entered into a securities purchase agreement (the “Agreement”) with a certain group of inves
Matinas BioPharma Appoints Evelyn D’An to Board of Directors as Audit Committee Chair
GlobeNewswire Inc.
Feb 07, 2025 12:30 PM GMT
BEDMINSTER, N.J., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) today announced the appointment of Evelyn D’An to its Board of Directors as an independent director and Chair of the Audit Committee, effecti